Article

Oncology Nurses and Chemotherapy Management

Oncology nurses that they play an important role in the administration of chemotherapy treatment.

It’s certainly not news to oncology nurses that they play an important role in the administration of chemotherapy treatment and “are key in the assessment and management of CINV.” With more than one million patients undergoing chemotherapy every year—approximately 70% of whom will experience chemotherapy-induced nausea and vomiting (CINV)—it is absolutely necessary to have control over CINV in order for patients to complete their treatment.

Patients who tend to be at a higher risk for CINV include:

  • Females
  • Those younger than age 50 years
  • Those with little or no history of alcohol intake
  • Those who experienced emesis with past pregnancy
  • Those with a history of motion sickness

During the Oncology Nursing Society’s annual Congress held in Philadelphia, PA, an electronic survey was conducted among 581 oncology nurses about treatment-related side effects, specifically CINV. The survey results showed that 56% (325 nurses) “report having had to stop or delay their patients’ treatment because of [CINV] and they cite it as one of the most important factors, after fatigue, that affect cancer patients’ quality of life.” Barbara Rogers, CRNP, MN, AOCN, Adult Hematology-Oncology Nurse Practitioner, Fox Case Cancer Center, said, “These survey data highlight the need for improved strategies, including a zero tolerance policy, to manage the nausea and vomiting that affect our patients’ lives as they undergo chemotherapy.”

If 325 out of 581 oncology nurses responded this way, how many oncology nurses who did not participate in the survey have also had to stop or delay a patient’s treatment due to CINV? Have you? E-mail me your experiences with treating patients with CINV!

Related News and Resources:

Control of CINV: Sparking Change in Your Practice

Managing Nausea and Vomiting

New management strategies for CINV

Past, Present and Future of Chemotherapy Induced Nausea and Vomiting

Patients needlessly suffering from chemotherapy induced nausea and vomiting

Putting evidence into practice: Evidence-based interventions to prevent, manage, and treat chemotherapy-induced nausea and vomiting

Related Videos
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
© 2024 MJH Life Sciences

All rights reserved.